These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17903670)

  • 1. Calf muscle volume estimates: implications for botulinum toxin treatment?
    Bandholm T; Sonne-Holm S; Thomsen C; Bencke J; Pedersen SA; Jensen BR
    Pediatr Neurol; 2007 Oct; 37(4):263-9. PubMed ID: 17903670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin injection site localization for the tibialis posterior muscle.
    Oddy MJ; Brown C; Mistry R; Eastwood DM
    J Pediatr Orthop B; 2006 Nov; 15(6):414-7. PubMed ID: 17001247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
    Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Lücke D; Malezic M; Bertelt C; Friedrich H; Gregoric M; Mauritz KH
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1321-4. PubMed ID: 7964805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum Toxin Treatment for Calf Contouring Based on the Study of Combined Injection of Gastrocnemius and Soleus.
    Li Z; Chong Y; Jin L; Zeng A; Huang J; Long X; Yu N; Wang X
    Aesthet Surg J; 2024 Apr; 44(5):545-555. PubMed ID: 38064673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of gastrocnemius muscle volume using ultrasonography in children with spastic cerebral palsy.
    Park ES; Sim E; Rha DW; Jung S
    Yonsei Med J; 2014 Jul; 55(4):1115-22. PubMed ID: 24954345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonographic analysis of the calves for efficient botulinum toxin type A injection.
    Chong Y; Li Z; Zhang D; Jin L; Chen C; Yu N; Long X
    J Cosmet Dermatol; 2022 Oct; 21(10):4301-4306. PubMed ID: 35894831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations.
    Borg-Stein J; Pine ZM; Miller JR; Brin MF
    Am J Phys Med Rehabil; 1993 Dec; 72(6):364-8. PubMed ID: 8260129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of neural lesion type on botulinum toxin dosage: a retrospective chart review.
    Phadke CP; Davidson C; Ismail F; Boulias C
    PM R; 2014 May; 6(5):406-11. PubMed ID: 24211697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
    Rousseaux M; Compère S; Launay MJ; Kozlowski O
    J Neurol Sci; 2005 May; 232(1-2):51-7. PubMed ID: 15850582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonography-guided injection of botulinum toxin in children with cerebral palsy.
    Berweck S; Schroeder AS; Fietzek UM; Heinen F
    Lancet; 2004 Jan; 363(9404):249-50. PubMed ID: 14738817
    [No Abstract]   [Full Text] [Related]  

  • 12. Botulinum toxin in treating spasticity.
    Das TK; Park DM
    Br J Clin Pract; 1989 Nov; 43(11):401-3. PubMed ID: 2611094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra- and intramuscular nerves distributions of the triceps surae muscle as a basis for muscle resection and botulinum toxin injections.
    Sheverdin VA; Hur MS; Won SY; Song WC; Hu KS; Koh KS; Kim HJ
    Surg Radiol Anat; 2009 Oct; 31(8):615-21. PubMed ID: 19300894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions to the understanding of gait control.
    Simonsen EB
    Dan Med J; 2014 Apr; 61(4):B4823. PubMed ID: 24814597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
    Mirska A; Cybula K; Okurowska-Zawada B; Kułak W; Dmitruk E; Okulczyk K; Kalinowska AK
    J Pediatr Orthop B; 2014 Nov; 23(6):517-22. PubMed ID: 25171568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of motor end plate-targeted Botulinum toxin type A injections in children with cerebral palsyitle.
    Van Campenhout A; Bar-On L; Desloovere K; Molenaers G
    Acta Orthop Belg; 2015 Jun; 81(2):167-71. PubMed ID: 26280952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
    Williams SA; Reid S; Elliott C; Shipman P; Valentine J
    Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
    Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
    J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical guide to botulinum neurotoxin treatment of teres major muscle in shoulder spasticity: Intramuscular neural distribution of teres major muscle in cadaver model.
    Yi KH; Lee KW; Hu HW; Lee JH; Lee HJ
    PM R; 2024 Feb; 16(2):160-164. PubMed ID: 37526565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.